NanoSight Receives £925,000 in Funding Round to Expand their Nanoparticle Characterization Business
News Nov 06, 2008
NanoSight Limited, the nanoparticle characterization company, has announced the completion of a new round of financing which will provide £925,000 to enable the company to expand the business with the development of new products and sales channels in the US market.
NanoSight has just closed almost £1m of investment finance in a month that has seen unprecedented financial turmoil worldwide. Having been close to breakeven for the first half of 2008, hitting sales targets and with margins better than anticipated, it was clear to the company that growth was limited by resource but not by market opportunity.
Having successfully weathered the start-up process during the past four years, NanoSight can become more robust with investment in personnel, technical support and development of the underlying technology, the company says.
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018